Quality of published studies supporting off-label and accelerated approval oncology indications

被引：0
|
作者：
Carson, K. R.
Chia, Y.
Sekhar, J.
Coeytaux, R. R.
Wheeler, J. L.
Bennett, C. L.
Abernethy, A. P.
机构：
[1] Washington Univ, St Louis, MO USA
[2] Barnes Jewish Hosp, St Louis, MO 63110 USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[5] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[6] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.6059
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6059
引用
收藏
页数：1
相关论文
共 50 条
  • [41] ASCO Advocacy for Coverage of Off-Label Oncology Drug Uses
    不详
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2006, 2 (05) : 225 - 226
  • [42] Conflict of Interest Disclosure in Off-Label Oncology Clinical Trials
    Irwin, Blair
    Hirsch, Bradford R.
    Samsa, Gregory P.
    Abernethy, Amy P.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2012, 8 (05) : 298 - 302
  • [43] Off-label drug use in oncology: a systematic review of literature
    Saiyed, M. M.
    Ong, P. S.
    Chew, L.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (03) : 251 - 258
  • [44] The ethics of off-label use of drugs: oncology pharmacy in Italy
    Bernardi, A.
    Pegoraro, R.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (02) : 95 - 99
  • [45] Off-label Studies on the Use of Ruxolitinib in Dermatology
    Tegtmeyer, Kyle
    Ravi, Mohan
    Zhao, Jeffrey
    Maloney, Nolan J.
    Lio, Peter A.
    [J]. DERMATITIS, 2021, 32 (03) : 164 - 172
  • [46] Off-Label studies on anakinra in dermatology: a review
    Tegtmeyer, Kyle
    Atassi, Giancarlo
    Zhao, Jeffrey
    Maloney, Nolan J.
    Lio, Peter A.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 73 - 86
  • [47] Off-label studies on ruxolitinib in dermatology: a review
    Wu, Jessica
    Smogorzewski, Jan
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 606 - 612
  • [48] Off-label studies on apremilast in dermatology: a review
    Maloney, Nolan J.
    Zhao, Jeffrey
    Tegtmeyer, Kyle
    Lee, Ernest Y.
    Cheng, Kyle
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (02) : 131 - 140
  • [49] Off-label studies on tofacitinib in dermatology: a review
    Tegtmeyer, Kyle
    Zhao, Jeffrey
    Maloney, Nolan J.
    Atassi, Giancarlo
    Beestrum, Molly
    Lio, Peter A.
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (04) : 399 - 409
  • [50] Label versus off-label use for an antibiotic with clearly defined approval (indication) in Dresden, Saxony
    Siegert, J.
    Schindler, C.
    Brecht, B.
    Fuchs, A.
    Kirch, W.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 369 - 369
12345